EDGAR Filing Documents for 0000950123-01-001494

Form 424B3 - Prospectus [Rule 424(b)(3)]:

SEC Accession No. 0000950123-01-001494

Filing Date

2001-02-15

Accepted

2001-02-15 00:00:00

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	NYMOX PHARMACEUTICAL CORPORATION: PROS SUPPLEMENT	m08934b3e424b3.txt	424B3	2059
	Complete submission text file	0000950123-01-001494.txt		3545

Mailing Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT, QUEBEC CANADA, H4M 2V2 A8

Business Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT, QUEBEC CANADA H4M 2V2 A8 514-332-3222

NYMOX PHARMACEUTICAL CORP (Filer) CIK: 0001018735 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-31310 | Film No.: 1547114
SIC: 2835 In Vitro & In Vivo Diagnostic Substances